Walleye Trading LLC Omeros Corp Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.81 - $5.69 $48,517 - $98,243	17,266 New	17,266 $50,000
Q2 2022 Aug 08, 2022	SELL	$1.92 - $6.28 $32,705 - $106,973	-17,034 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $31,895 - $45,295	-6,291 Reduced 26.97%	17,034 $102,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $3,929 - $5,918	693 Added 3.06%	23,325 $150,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $286,224 - $348,168	21,360 Added 1679.25%	22,632 $312,000
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $18,838 - $24,333	1,272 New	1,272 $19,000
Q2 2020 Aug 14, 2020	SELL	$12.21 - $16.99 $152,429 - $212,103	-12,484 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $112,730 - $246,184	12,484 New	12,484 $167,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $22,605 - $29,567	-1,507 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $12,826 - $19,509	-1,101 Reduced 42.22%	1,507 $26,000
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $46,239 - $69,607	2,608 New	2,608 $64,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.